*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C678 - Malignant neoplasm of overlapping sites of bladder - as a primary diagnosis code | C678 - Malignant neoplasm of overlapping sites of bladder - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.85 | |
| Readmission Rate (%) | 29.59 | |
| Unplanned Readmission Rate (%) | 18.91 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 653: MAJOR BLADDER PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 670: TRANSURETHRAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 13,513 | ||||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 1,412 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 29.0 | ||||
| Avg LOS at DRG | 7.02 | ||||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 7.57 | ||||
| Readmission Rate at DRG | 26.89 | ||||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 32.99 | ||||
| Unplanned Readmission Rate at DRG | 18.36 | ||||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 23.19 | ||||
| Total Medicare payments at DRG | $270,065,366 | ||||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $31,003,028 | ||||
| Total Medicare payment per Day at DRG | $2,848 | ||||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $2,902 | ||||
| Total Medicare payment per Hospitalization at DRG | $19,986 | ||||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $21,957 | ||||
| Total Medicare Charges at DRG | $1,412,381,149 | ||||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $167,094,998 | ||||
| Avg Charges at DRG | $104,520 | ||||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $118,339 | ||||
| Mortality Rate at DRG | 0.21 | ||||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||||
| SNF Discharge Rate at DRG | 15.04 | ||||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 16.93 | ||||
| Home Discharge Rate at DRG | 33.15 | ||||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 24.08 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 668: TRANSURETHRAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 686: KIDNEY AND URINARY TRACT NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 666: PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 10,891 | ||||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 333 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 6.84 | ||||
| Avg LOS at DRG | 8.48 | ||||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 9.11 | ||||
| Readmission Rate at DRG | 28.33 | ||||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 30.51 | ||||
| Unplanned Readmission Rate at DRG | 20.09 | ||||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 22.03 | ||||
| Total Medicare payments at DRG | $184,732,838 | ||||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $5,901,742 | ||||
| Total Medicare payment per Day at DRG | $2,001 | ||||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $1,946 | ||||
| Total Medicare payment per Hospitalization at DRG | $16,962 | ||||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $17,723 | ||||
| Total Medicare Charges at DRG | $955,216,524 | ||||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $31,559,535 | ||||
| Avg Charges at DRG | $87,707 | ||||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $94,773 | ||||
| Mortality Rate at DRG | 3.54 | ||||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 5.71 | ||||
| SNF Discharge Rate at DRG | 27.45 | ||||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 27.03 | ||||
| Home Discharge Rate at DRG | 35.91 | ||||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 30.33 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 656: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 663: MINOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 667: PROSTATECTOMY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 665: PROSTATECTOMY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 688: KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 9,147 | ||||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 57 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 1.17 | ||||
| Avg LOS at DRG | 7.7 | ||||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 12.88 | ||||
| Readmission Rate at DRG | 22.73 | ||||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 24.53 | ||||
| Unplanned Readmission Rate at DRG | 14.03 | ||||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 22.64 | ||||
| Total Medicare payments at DRG | $223,297,640 | ||||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $1,580,860 | ||||
| Total Medicare payment per Day at DRG | $3,171 | ||||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $2,154 | ||||
| Total Medicare payment per Hospitalization at DRG | $24,412 | ||||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $27,734 | ||||
| Total Medicare Charges at DRG | $1,075,956,818 | ||||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $7,134,952 | ||||
| Avg Charges at DRG | $117,629 | ||||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $125,175 | ||||
| Mortality Rate at DRG | 3.71 | ||||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||||
| SNF Discharge Rate at DRG | 15.17 | ||||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 22.81 | ||||
| Home Discharge Rate at DRG | 54.47 | ||||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 674: OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | |
|---|---|---|---|
| Total Hospitalizations at DRG | 17,122 | ||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 18 | ||
| DRG Share of Total Hospitalizations | 0.05 | ||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 0.37 | ||
| Avg LOS at DRG | 7.0 | ||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 6.44 | ||
| Readmission Rate at DRG | 26.1 | ||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||
| Unplanned Readmission Rate at DRG | 18.72 | ||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||
| Total Medicare payments at DRG | $258,914,062 | ||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $295,733 | ||
| Total Medicare payment per Day at DRG | $2,160 | ||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $2,549 | ||
| Total Medicare payment per Hospitalization at DRG | $15,122 | ||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $16,430 | ||
| Total Medicare Charges at DRG | $1,311,882,981 | ||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $1,374,426 | ||
| Avg Charges at DRG | $76,620 | ||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $76,357 | ||
| Mortality Rate at DRG | 0.41 | ||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||
| SNF Discharge Rate at DRG | 17.23 | ||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||
| Home Discharge Rate at DRG | 58.05 | ||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 61.11 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 175 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 123 |
| UNIVERSITY OF MICHIGAN HEALTH SYSTEM | 1500 EAST MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 98 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MICHAEL CHRISTOPHER LARGE | 8040 CLEARVISTA PKWY | INDIANAPOLIS | IN | 46256 | 61 |
| Dr. ASHISH M. KAMAT | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 56 |
| Dr. KAMAL S. POHAR | 915 OLENTANGY RIVER RD | COLUMBUS | OH | 43212 | 51 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ASHISH M. KAMAT | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 56 |
| Dr. MICHAEL CHRISTOPHER LARGE | 8040 CLEARVISTA PKWY | INDIANAPOLIS | IN | 46256 | 56 |
| Dr. KAMAL S. POHAR | 915 OLENTANGY RIVER RD | COLUMBUS | OH | 43212 | 51 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 653: MAJOR BLADDER PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 670: TRANSURETHRAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 13,513 | ||||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 1,464 | ||||
| DRG Share of Total Hospitalizations | 0.04 | ||||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 18.18 | ||||
| Avg LOS at DRG | 7.02 | ||||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 7.51 | ||||
| Readmission Rate at DRG | 26.89 | ||||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 32.67 | ||||
| Unplanned Readmission Rate at DRG | 18.36 | ||||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 22.79 | ||||
| Total Medicare payments at DRG | $270,065,366 | ||||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $31,916,314 | ||||
| Total Medicare payment per Day at DRG | $2,848 | ||||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $2,903 | ||||
| Total Medicare payment per Hospitalization at DRG | $19,986 | ||||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $21,801 | ||||
| Total Medicare Charges at DRG | $1,412,381,149 | ||||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $172,222,580 | ||||
| Avg Charges at DRG | $104,520 | ||||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $117,638 | ||||
| Mortality Rate at DRG | 0.21 | ||||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||||
| SNF Discharge Rate at DRG | 15.04 | ||||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 16.8 | ||||
| Home Discharge Rate at DRG | 33.15 | ||||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 24.32 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 668: TRANSURETHRAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 10,891 | ||||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 382 | ||||
| DRG Share of Total Hospitalizations | 0.03 | ||||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 4.74 | ||||
| Avg LOS at DRG | 8.48 | ||||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 9.27 | ||||
| Readmission Rate at DRG | 28.33 | ||||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 31.09 | ||||
| Unplanned Readmission Rate at DRG | 20.09 | ||||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 21.99 | ||||
| Total Medicare payments at DRG | $184,732,838 | ||||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $6,838,657 | ||||
| Total Medicare payment per Day at DRG | $2,001 | ||||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $1,930 | ||||
| Total Medicare payment per Hospitalization at DRG | $16,962 | ||||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $17,902 | ||||
| Total Medicare Charges at DRG | $955,216,524 | ||||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $36,407,828 | ||||
| Avg Charges at DRG | $87,707 | ||||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $95,308 | ||||
| Mortality Rate at DRG | 3.54 | ||||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 5.76 | ||||
| SNF Discharge Rate at DRG | 27.45 | ||||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 26.96 | ||||
| Home Discharge Rate at DRG | 35.91 | ||||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 30.63 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 686: KIDNEY AND URINARY TRACT NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 102 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 1.27 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 4.72 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 30.53 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 18.95 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $874,576 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $1,818 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $8,574 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $3,928,588 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $38,516 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 17.65 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 39.22 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 666: PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 269,064 | ||||
| Total Hospitalizations with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 100 | ||||
| DRG Share of Total Hospitalizations | 0.82 | ||||
| % of Total ICD C678 - Malignant neoplasm of overlapping sites of bladder in DRG | 1.24 | ||||
| Avg LOS at DRG | 13.18 | ||||
| Avg LOS with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 14.06 | ||||
| Readmission Rate at DRG | 37.51 | ||||
| Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 35.16 | ||||
| Unplanned Readmission Rate at DRG | 18.15 | ||||
| Unplanned Readmission Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 21.98 | ||||
| Total Medicare payments at DRG | $9,344,186,034 | ||||
| Total Medicare payments with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $3,455,467 | ||||
| Total Medicare payment per Day at DRG | $2,635 | ||||
| Total Medicare payment per Day with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $2,458 | ||||
| Total Medicare payment per Hospitalization at DRG | $34,728 | ||||
| Total Medicare payment per Hospitalization with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $34,555 | ||||
| Total Medicare Charges at DRG | $44,371,117,432 | ||||
| Total Medicare Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $13,520,908 | ||||
| Avg Charges at DRG | $164,909 | ||||
| Avg Charges with ICD C678 - Malignant neoplasm of overlapping sites of bladder | $135,209 | ||||
| Mortality Rate at DRG | 14.37 | ||||
| Mortality Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | NA | ||||
| SNF Discharge Rate at DRG | 31.8 | ||||
| SNF Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 41.0 | ||||
| Home Discharge Rate at DRG | 14.61 | ||||
| Home Discharge Rate with ICD C678 - Malignant neoplasm of overlapping sites of bladder | 18.0 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 424 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 227 |
| ARTHUR G JAMES CANCER HOSPITAL | 300 W 10TH AVE | COLUMBUS | OH | 43210 | 154 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MICHAEL CHRISTOPHER LARGE | 8040 CLEARVISTA PKWY | INDIANAPOLIS | IN | 46256 | 66 |
| Dr. ASHISH M. KAMAT | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 60 |
| Dr. KAMAL S. POHAR | 915 OLENTANGY RIVER RD | COLUMBUS | OH | 43212 | 53 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. MICHAEL CHRISTOPHER LARGE | 8040 CLEARVISTA PKWY | INDIANAPOLIS | IN | 46256 | 61 |
| Dr. ASHISH M. KAMAT | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 60 |
| Dr. GUIDO DALBAGNI | 1275 YORK AVE | NEW YORK | NY | 10021 | 57 |